Suppr超能文献

取代β-环糊精和杯[4]芳烃作为基于铂(II)的DNA嵌入剂的包封载体。

Substituted beta-cyclodextrin and calix[4]arene as encapsulatory vehicles for platinum(II)-based DNA intercalators.

作者信息

Krause-Heuer Anwen M, Wheate Nial J, Tilby Michael J, Pearson D Graham, Ottley Christopher J, Aldrich-Wright Janice R

机构信息

School of Biomedical and Health Sciences, University of Western Sydney, Locked Bag 1797, Penrith South DC, 1797, NSW, Australia.

出版信息

Inorg Chem. 2008 Aug 4;47(15):6880-8. doi: 10.1021/ic800467c. Epub 2008 Jul 2.

Abstract

The encapsulation of three platinum(II)-based anticancer complexes, [(5,6-dimethyl-1,10-phenanthroline)(1 S,2 S-diaminocyclohexane)platinum(II)] (2+) ( 56MESS), [(5,6-dimethyl-1,10-phenanthroline)(1 R,2 R-diaminocyclohexane)platinum(II)] (2+) ( 56MERR), and [(5,6-dimethyl-1,10-phenanthroline)(ethylenediamine)platinum(II)] (2+) ( 56MEEN), with carboxylated-beta-cyclodextrin (c-beta-CD) and p-sulfonatocalix[4]arene (s-CX[4]) has been examined by one- and two-dimensional (1)H nuclear magnetic resonance (NMR) spectroscopy, pulsed gradient spin-echo NMR, ultraviolet spectrophotometry, glutathione degradation experiments, and growth inhibition assays. Titration of any of the three metal complexes with c-beta-CD resulted in 1:1 encapsulation complexes with the cyclodextrin located over the intercalating ligand of the metal complexes, with a binding constant of 10 (4)-10 (5) M (-1). In addition to binding over the phenanthroline ligand of 56MEEN, c-beta-CD was also found to portal bind to the ethylenediamine ligand, with fast exchange kinetics on the NMR timescale between the two binding sites. In contrast, the three metal complexes all formed 2:2 inclusion complexes with s-CX[4] where the two metal complexes stacked in a head-to-tail configuration and were capped by the s-CX[4] molecules. Interestingly, the 56MEEN-s-CX[4] complex appeared to undergo a thermodynamically controlled rearrangement to a less soluble complex over time. Encapsulation of the metal complexes in either c-beta-CD or s-CX[4] significantly decreased the metal complexes' rate of diffusion, consistent with the formation of larger particle volumes. Encapsulation of 56MESS within s-CX[4] or c-beta-CD protected the metal complex from degradation by reduced L-glutathione, with a reaction half-life greater than 9 days. In vitro growth inhibition assays using the LoVo human colorectal cancer cell line showed no significant change in the cytotoxicity of 56MESS when encapsulated by either s-CX[4] or c-beta-CD.

摘要

通过一维和二维¹H核磁共振(NMR)光谱、脉冲梯度自旋回波NMR、紫外分光光度法、谷胱甘肽降解实验和生长抑制测定,研究了三种铂(II)基抗癌配合物,即(5,6-二甲基-1,10-菲咯啉)(1S,2S-二氨基环己烷)铂(II)(56MESS)、(5,6-二甲基-1,10-菲咯啉)(1R,2R-二氨基环己烷)铂(II)(56MERR)和(5,6-二甲基-1,10-菲咯啉)(乙二胺)铂(II)(56MEEN)与羧基化β-环糊精(c-β-CD)和对磺基杯[4]芳烃(s-CX[4])的包封情况。用c-β-CD滴定这三种金属配合物中的任何一种,都会形成1:1的包封配合物,其中环糊精位于金属配合物的插入配体上方,结合常数为10⁴ - 10⁵ M⁻¹。除了在56MEEN的菲咯啉配体上结合外,还发现c-β-CD通过门户与乙二胺配体结合,在NMR时间尺度上两个结合位点之间具有快速交换动力学。相比之下,这三种金属配合物都与s-CX[4]形成了2:2的包合物,其中两个金属配合物以头对尾的构型堆叠,并由s-CX[4]分子封端。有趣的是,56MEEN-s-CX[4]配合物似乎会随着时间的推移发生热力学控制的重排,形成溶解度较小的配合物。将金属配合物包封在c-β-CD或s-CX[4]中会显著降低金属配合物的扩散速率,这与形成更大的颗粒体积一致。将56MESS包封在s-CX[4]或c-β-CD中可保护金属配合物不被还原型L-谷胱甘肽降解,反应半衰期大于9天。使用LoVo人结肠癌细胞系进行的体外生长抑制测定表明,当56MESS被s-CX[4]或c-β-CD包封时,其细胞毒性没有显著变化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验